Only Clinic in Minnesota able to predict risk factors for Macular Degeneration, the leading cause of legal blindness in the world.
Uptown Eye Care is now able to provide proactive detection of one of the main risk factors of Age-related Macular Degeneration (AMD), the leading cause of legal blindness in the world today. With the help of MacuScope, Uptown Eye Care can now identify those patients who are at risk for developing AMD.
“Uptown Eye Care will be the first within the state of Minnesota to offer MacuScope,” says Dr. Elaine Happ of Uptown Eye Care. “We are able to offer something truly innovational to the people of Minnesota.”
AMD currently affects more than 30 million people worldwide. According to the National Eye Institute, the figure could soon approach epidemic proportions, easily doubling in the next 20 to 30 years. It severely affects a person’s central vision making it extremely difficult, if not impossible, to read, drive or perform other activities that require fine, detailed vision.
“Early detection of this Age-related disease is critical to preserving one’s vision,” said Dr. Elaine Happ.
Upon evaluation and detection of those at high risk, Uptown Eye Care will develop a treatment program using specific supplements to manage the deficiency. Research had proven that treatment with specific supplements can increase macular protective pigment density within six months.
“A medical device such as MacuScope is a beneficial addition to Uptown Eye Care. We are pleased to be able to offer testing to our patients which could help save their eyesight,” said Dr. Happ.